We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTX icon
13176
PUT
Avalo Therapeutics
AVTX
$1.05B
$58K ﹤0.01%
9
+1
+13% +$8.11K
BQ
13177
PUT
Boqii Holding Ltd
BQ
$8.19M
$58K ﹤0.01%
125
-10
-7% -$6.08K
PRHI
13178
Presurance Holdings
PRHI
$23.6M
$58K ﹤0.01%
+2,897
New +$60.6K
LPCN icon
13179
PUT
Lipocine
LPCN
$17.4M
$58K ﹤0.01%
3,135
-118
-4% -$2.6K
QDROW
13180
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$58K ﹤0.01%
+75,947
New +$54.4K
BDSI
13181
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$58K ﹤0.01%
+16,075
New +$60.6K
BNBX
13182
PUT
DELISTED
BNB PLUS CORP
BNBX
$57K ﹤0.01%
+1
New +$86.7K
CDTX
13183
DELISTED
Cidara Therapeutics
CDTX
$57K ﹤0.01%
1,282
+639
+99% +$24.3K
GASS icon
13184
CALL
StealthGas
GASS
$352M
$57K ﹤0.01%
21,100
-47,900
-69% -$127K
JFIN
13185
Jiayin Group
JFIN
$119M
$57K ﹤0.01%
15,213
-8,682
-36% -$36.5K
MYPSW
13186
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
$57K ﹤0.01%
73,893
-390
-0.5% -$419
UAMY icon
13187
CALL
United States Antimony
UAMY
$825M
$57K ﹤0.01%
63,400
+33,200
+110% +$30.6K
SRT
13188
PUT
DELISTED
Startek Inc.
SRT
$57K ﹤0.01%
+10,400
New +$64K
FRTX
13189
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$57K ﹤0.01%
1,768
-18
-1% -$584
NYMX
13190
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$57K ﹤0.01%
27,900
+15,100
+118% +$26.8K
QTT
13191
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$57K ﹤0.01%
5,791
-1,249
-18% -$17.9K
TCDA
13192
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$57K ﹤0.01%
12,300
-111,200
-90% -$461K
CPTK.WS
13193
DELISTED
Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CPTK.WS
$57K ﹤0.01%
112,385
+84,119
+298% +$59.6K
AUTO
13194
PUT
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$57K ﹤0.01%
20,400
-7,500
-27% -$21.1K
AFI
13195
CALL
DELISTED
Armstrong Flooring, Inc.
AFI
$57K ﹤0.01%
18,300
-700
-4% -$2.88K
GCACW
13196
DELISTED
Growth Capital Acquisition Corp. Warrant
GCACW
$57K ﹤0.01%
61,158
-1,703
-3% -$1.33K
AAME icon
13197
Atlantic American Corp
AAME
$29.6M
$56K ﹤0.01%
13,422
-1,592
-11% -$6.43K
APWC icon
13198
Asia Pacific Wire & Cable
APWC
$62.7M
$56K ﹤0.01%
17,366
+2,942
+20% +$9.8K
CPRX
13199
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$56K ﹤0.01%
+10,500
New +$57.4K
JG
13200
Aurora Mobile
JG
$34.2M
$56K ﹤0.01%
1,687
-1,676
-50% -$74.9K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.